Protagonist Therapeutics Inc buy Barclays PLC
Start price
19.03.26
/
50%
€88.00
Target price
19.03.27
€103.58
Performance (%)
-2.84%
Price
04.05.26
€85.50
Summary
This prediction is currently active. With a performance of -2.84%, the BUY prediction for Protagonist Therapeutics Inc by Barclays_PLC is down slightly. This prediction currently runs until 19.03.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -1.156% | -1.156% |
| iShares Core DAX® | 4,64 % | 7,49 % |
| iShares Nasdaq 100 | 4,47 % | 16,80 % |
| iShares Nikkei 225® | 7,67 % | 16,86 % |
| iShares S&P 500 | 2,47 % | 9,90 % |
Comments by Barclays_PLC for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its price target raised by Barclays PLC from $113.00 to $119.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Barclays_PLC for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€77.00
26.02.26
26.02.26
€95.61
26.02.27
26.02.27
11.04%
04.05.26
04.05.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
07.11.25
07.11.25
€76.27
07.11.26
07.11.26
23.91%
04.05.26
04.05.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€53.00
17.09.25
17.09.25
€60.73
17.09.26
17.09.26
61.32%
04.05.26
04.05.26